Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction.
- Published In:
- ESC heart failure, 12(1), 517-524 (2025)
- Authors:
- Chu, Song-Yun, Peng, Fen, Wang, Jie, Liu, Lin, Zhao, Jing, Han, Xiao-Ning, Ding, Wen-Hui
- Database ID:
- RPEP-10493
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10493APA
Chu, Song-Yun; Peng, Fen; Wang, Jie; Liu, Lin; Zhao, Jing; Han, Xiao-Ning; Ding, Wen-Hui. (2025). Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction.. ESC heart failure, 12(1), 517-524. https://doi.org/10.1002/ehf2.15107
MLA
Chu, Song-Yun, et al. "Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction.." ESC heart failure, 2025. https://doi.org/10.1002/ehf2.15107
RethinkPeptides
RethinkPeptides Research Database. "Catestatin as a predictor for cardiac death in heart failure..." RPEP-10493. Retrieved from https://rethinkpeptides.com/research/chu-2025-catestatin-as-a-predictor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.